NEUTRALIZING ANTIBODIES IN ABORTIVE POLIOMYELITIS
نویسندگان
چکیده
منابع مشابه
Neutralizing Antibodies in Abortive Poliomyelitis
The neutralizing antibody content for poliomyelitis virus has been tested with both a human and a passage strain of the virus in serial samples of sera from five mild cases of abortive poliomyelitis, and an increase in this antibody content has been demonstrated in convalescent samples obtained within 4 weeks of the acute illness.
متن کاملThe Detection of Poliomyelitis Virus in so Called Abortive Types of the Disease
Experiments are reported which describe the isolation of poliomyelitis virus from the throats of two patients during an attack of so called abortive poliomyelitis (Wickman type), or what we have termed characteristic minor illnesses in association with poliomyelitis. This finding represents added evidence in favor of the belief, previously held by many observers, that certain types of minor ill...
متن کاملNeutralizing antibodies against interferon-Beta.
The development of neutralizing antibodies (NAbs) is a major problem in multiple sclerosis (MS) patients treated with interferon-beta (IFN-ß). Whereas binding antibodies (BAbs) can be demonstrated in the vast majority of patients, only a smaller proportion of patients develop NAbs. The principle in NAb in vitro assays is the utilization of cultured cell lines that are responsive to IFN-ß. The c...
متن کاملTat-neutralizing antibodies in vaccinated macaques.
The human immunodeficiency virus Tat protein is essential for virus replication and is a candidate vaccine antigen. Macaques immunized with Tat or chemically modified Tat toxoid having the same clade B sequence developed strong antibody responses. We compared these antisera for their abilities to recognize diverse Tat sequences. An overlapping peptide array covering three clade B and two clade ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Experimental Medicine
سال: 1933
ISSN: 1540-9538,0022-1007
DOI: 10.1084/jem.58.5.531